The Similarities of Thematic Progression in Zodiac Killer Letters [PDF]
Mohammad Rakhmat Pramudita +2 more
exaly +2 more sources
ABSTRACT We describe the background of the Zodiac killer’s cipher, and present a strategy for how to attack the unsolved Z340 cipher. We present evidence that there is a high degree of non-randomness in the sequence of ciphertext symbols in this cipher, suggesting it has been constructed in a systematic way.
Håvard Raddum, Marek Sýs
openaire +1 more source
The Solution of the Zodiac Killer's 340-Character Cipher
The case of the Zodiac Killer is one of the most widely known unsolved serial killer cases in history. The unidentified killer murdered five known victims and terrorized the state of California. He also communicated extensively with the press and law enforcement. Besides his murders, Zodiac was known for his use of ciphers.
David Oranchak +2 more
openaire +2 more sources
Deciphering the Zodiac Killer: A Killer Betrayed by his own Words
Between December 1968 and October 1969, an unknown man terrorized the San Francisco Bay Area of California, murdering five people and wounding two others. The murderer adopted the moniker Zodiac and proceeded to mail taunting letters, cards, and cryptograms to law enforcement and newspapers, possibly leading to clues to his identity.
openaire +1 more source
NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the BRACE CORONA Randomized Trial. [PDF]
Moll-Bernardes R +25 more
europepmc +1 more source
A Vigenère Solution to the Zodiac Killer's Z13 Cipher: MY NAME IS LEIGH
THE BREAKTHROUGH: Nobody in 55 years treated "My name is" as part of the encrypted message. Every previous attempt assumed the 13 cipher characters contained a complete name. They don't. "My name is" IS the plaintext for columns 1–8. The cipher only hides 5 characters — a single first name.
openaire +2 more sources
Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence. [PDF]
Cavalcante FP +12 more
europepmc +1 more source
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. [PDF]
Diab A +25 more
europepmc +1 more source
PD-L1 testing in advanced gastric cancer-what physicians who treat this disease must know-a literature review. [PDF]
Peixoto RD +13 more
europepmc +1 more source
Progress and challenges in exploring aquatic microbial communities using non-targeted metabolomics. [PDF]
Thukral M, Allen AE, Petras D.
europepmc +1 more source

